Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 580 results for "zhang chi"

Cartoon Commentary, Xi's Lat-Am trip ⑥: Setting new model fo...

By Zhang Maorong, researcher with the China Institute of Contemporary International Relations; cartoon drawn by Chi Ying At the invitation of Chilean President Michelle Bachelet, Chinese President Xi Jinping paid a state visit to Chile on ... Xinhua News Agency, 1 month ago

8 images for zhang chi

Global Times, 1 week ago
Global Times, 1 week ago
Global Times, 1 week ago
Global Times, 1 week ago
Times of India, 3 months ago
CHINAdaily.com.cn, 2 months ago
The Times Of Israel, 4 months ago
Ecns.cn, 5 months ago

Nanosecond pulsed electric fields enhance the anti-tumour effects of the mTOR inhibitor Everolimus against melanoma. Dai J, Wu S, Kong Y, Chi Z, Si L, Sheng X, Cui C, Fang J, Zhang J, Guo J Sci Rep 2017; 7

By: Dai J, Wu S, Kong Y, Chi Z, Si L, Sheng X, Cui C, Fang J, Zhang J, Guo J Published in: Sci Rep 2017; 7: 39597 Journal PubMed DOI: 10.1038/srep39597 Exposure electric field signals/ pulses
 EMF-Portal2 weeks ago
Globes

El nuevo fondo Kuang-Chi GCI de 250 millones de dólares se centra en las oportunidades tecnológicas de Israel

El doctor RuopengLiu, presidente de Kuang-Chi, dijo: "Pudimos desplegar rápidamente el GCI Fund I de 50 millones de dólares estadounidenses en compañías excepcionales que operan en sectores que conocemos bien y nos gustaría seguir construyendo ...
 PR Newswire1 week ago Nuevo GCI Fund de USD250 millones se enfoca en oportunidades tecnológicas en Israel  PR Newswire1 week ago Neuer 250 Millionen USD Kuang-Chi GCI-Fonds konzentriert sich auf technologische Möglichkeiten in Israel  PR Newswire1 week ago Novo Fundo GCI de US$ 250 milhões da Kuang-Chi foca nas oportunidades tecnológicas de Israel  PR Newswire1 week ago
[x]  

Ownership confirmation dispute between Benxi-based Sanjiang Real Estate Development Co, Ltd, Chi Tongmin, Chi Tongyan, Chi Guosheng, Yang Fuhui, Wang Xuezheng, Yang Yuyang and Zhang Shichen

 CHINAdaily.com.cn1 month ago

E China's Six-Chi Lane story lightens Chinese wisdom

Photo provided by the author shows the Six-Chi Lane in east China's Anhui province. By Chen Yicheng The historic story of the Six-Chi Lane, (chi, a Chinese unit, 1/3 meter), rendered in the Huangmei opera, "Prime Minister of Qing Dynasty", was ...
 Xinhua News Agency1 month ago

New York (Goings On)

Updated: 2016-12-13 05:44 (China Daily USA) All the right moves — New York World famous tai chi quan master Chen Zhenglei (center) demonstrates his technique on Thursday at UN headquarters in New York. Chen expressed his hopes that more ...
 CHINAdaily USA1 month ago

Economic Watch: China's A-shares market accelerating in volume, influence

by Xinhua writer Zhang Zhongkai BEIJING, Dec. 11 (Xinhua) -- As China's first college teacher to teach stock market investment, 25 years ago, Pan Fuxiang was excited as the number of companies listed on the country's A-shares market surpassed 3,000 ...
 Xinhua News Agency1 month ago

Angela Zhang Brings Back Classic Mandopop Songs at her World Tour Concert Stop in Singapore!

Photo Courtesy of: IMC Live Taiwanese Mandopop songstress Angela Zhang Shao Han proves to be the queen of the C-pop genre at her 100% Angela Zhang World Tour Singapore Concert last night, held at the Suntec Convention Centre. Apart from ...
 Yahoo! Singapore1 month ago

Fruquintinib Phase I/II Clinical Data at ASCO GI

Chi-Med completed a Phase Ib dose finding study of fruquintinib in combination with paclitaxel, which established a combination regimen that was well tolerated, and continued to enroll patients in this trial to expand the data-set. Additional ...
 MoneyAM6 days ago Hutchison China MediTech : Chi-Med Presents Phase I/II Clinical Data for Selective VEGFR Inhibitor Fruquintinib at the 2017 Gastrointestinal Cancers Symposium  4 Traders6 days ago Chi-Med Presents Phase I/II Clinical Data for Selective VEGFR Inhibitor Fruquintinib at the 2017 Gastrointestinal Cancers Symposium  Pharmacy Choice5 days ago Hutchison China MediTech (Chi-Med) Release: Company Presents Phase I/II Clinical Data For Selective VEGFR Inhibitor Fruquintinib At The  BioSpace5 days ago
[x]  

Hutchison China Meditech Limited: Fruquintinib Phase I/II Clinical Data at ASCO GI

- Hutchison China Meditech Limited (NASDAQ: HCM) (AIM: HCM) Press Release Chi-Med Presents Phase I/II Clinical Data for Selective VEGFR Inhibitor Fruquintinib at the 2017 Gastrointestinal Cancers Symposium London: Monday, January 16, 2017 : ...
 Financial Buzz5 days ago Hutchison China Meditech Limited Fruquintinib Phase I/II Clinical Data..  ADVFN UK6 days ago CHINA TONTINE WINES : Announcements and Notices - List of Directors and Their Role and Function  4 Traders2 months ago
[x]  
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less